{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 327,
  "pageCount": 415,
  "prevPage": 326,
  "nextPage": 328,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a bolded summary paragraph at the top, followed by a detailed Q&A transcript with yellow highlighting on key quotes.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/327",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-327",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "I don’t really know why a drug that’s targeted at children would ever be a tablet because it’s a nightmare...I don’t know they’ve picked a tablet over a suspension.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2b2-10a739609110",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.312,
        "w": 0.854,
        "x": 0.073,
        "y": 0.636
      },
      "kind": "quote",
      "text": "Q: \"Why would anybody use a tablet in this population with swallowing issues versus liquid suspension? Isn't that a superior formulation and also cheaper?\"\nA: \"No, absolutely. And I don't really know why a drug that's targeted at children would ever be a tablet because it's a nightmare...\"",
      "attrs": {
        "highlighted": true
      },
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f5ecebc-1e8b-419a-a55b-83542bc9ed2e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“I don’t really know why a drug that’s targeted at children would ever be a tablet because it’s a nightmare...I don’t know they’ve picked a tablet over a suspension...they say it’s because you need to give the suspension two to three times...they’re referring to what we do in hyperinsulinism which is a very different condition...because we want the sugars to be kept within a certain range, whereas in Prader-Willi Syndrome, managing the hyperphagia, it doesn’t need to be done in that similar way...so I don’t know why they picked that tablet.” — Trial investigator, pediatric endocrinologist",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2b2-15656e3e6423",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.073,
        "y": 0.956
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": {},
      "subkind": "source-note",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "71b47c1c-3045-48ea-a3a2-e5349b1d6add",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.854,
        "x": 0.073,
        "y": 0.591
      },
      "kind": "subtitle",
      "text": "Liquid diazoxide is vastly superior to Vykat tablet; misconception that liquid diazoxide needs to be dosed 2-3X per day; daily is fine for PWS patients; patients could chew Vykat which is contraindicated",
      "attrs": {
        "font-style": "italic",
        "text-decoration": "underline"
      },
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e7b647c-b7c3-46b0-ae1d-5ab77aace9c1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.491,
        "w": 0.854,
        "x": 0.073,
        "y": 0.071
      },
      "kind": "title",
      "text": "Trial investigator #6 stated that regular diazoxide suspension is vastly superior to Vykat's pill formulation and questioned the rationale for Soleno's formulation.",
      "attrs": {
        "font-weight": "bold",
        "text-decoration": "underline"
      },
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b8522df8-2c10-4ec4-98a1-b9a3e9ca6f38",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "03898775-93bc-439e-b071-433ed810b9b9",
      "evidence": "Trial investigator #6 stated...",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}